Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
about
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection.Etravirine for the treatment of HIV/AIDS.Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest.
P2860
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@en
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@nl
type
label
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@en
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@nl
prefLabel
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@en
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@nl
P2093
P50
P356
P1476
Safety of etravirine in HIV-1/ ...... rom the Phase III DUET trials.
@en
P2093
James Witek
Nathan Clumeck
Steven Nijs
P304
P356
10.1093/JAC/DKQ332
P407
P577
2010-08-27T00:00:00Z